Tenax Therapeutics, Inc. · NASDAQ:TENX
T. Rowe Price Associates Inc's stake in Tenax Therapeutics, Inc. fell to 2.20% (Schedule 13G/A)
Event May 31, 2026 · Filed Jun 5, 2026
T. Rowe Price Associates Inc's stake in Tenax Therapeutics, Inc. fell to 2.20%, 586,990 shares, as a passive investor on May 31, 2026. Filed Jun 5, 2026 (Schedule 13G/A).
- Stake
- 2.20%
- Shares
- 586,990
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| T. Rowe Price Associates, Inc. | 2.20% | 586,990 |
Source
Related
- Tenax Therapeutics, Inc.
- T. Rowe Price Associates Inc
- Tenax Therapeutics, Inc. shareholders
- Schedule 13G/A · T. Rowe Price Associates Inc · May 7, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · May 7, 2026
- Form 4 · ADAR1 Capital Management, LLC · Oct 21, 2026
- Schedule 13G/A · Millennium Management LLC · Oct 15, 2026
- Schedule 13G/A · Sphera Funds Management LTD. · Oct 13, 2026
- Schedule 13G/A · Dellora Investments LP · Oct 9, 2026
- Form 4 · Doogan Declan · Sep 17, 2026